INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 111 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $156,000 | +4.0% | 16,887 | 0.0% | 0.00% | – |
| Q4 2020 | $150,000 | -23.5% | 16,887 | 0.0% | 0.00% | – |
| Q3 2020 | $196,000 | -78.1% | 16,887 | -49.2% | 0.00% | -100.0% |
| Q2 2020 | $896,000 | +140.9% | 33,237 | -33.5% | 0.00% | 0.0% |
| Q1 2020 | $372,000 | +100.0% | 49,986 | -11.4% | 0.00% | – |
| Q4 2019 | $186,000 | +60.3% | 56,386 | 0.0% | 0.00% | – |
| Q3 2019 | $116,000 | -30.1% | 56,386 | +0.1% | 0.00% | – |
| Q2 2019 | $166,000 | +74.7% | 56,336 | +120.1% | 0.00% | – |
| Q1 2019 | $95,000 | -6.9% | 25,600 | 0.0% | 0.00% | – |
| Q4 2018 | $102,000 | -25.0% | 25,600 | -26.3% | 0.00% | – |
| Q2 2018 | $136,000 | -15.5% | 34,718 | +1.8% | 0.00% | – |
| Q1 2018 | $161,000 | +14.2% | 34,118 | 0.0% | 0.00% | – |
| Q4 2017 | $141,000 | +22.6% | 34,118 | +87.8% | 0.00% | – |
| Q3 2017 | $115,000 | – | 18,168 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 648,800 | $1,920,000 | 1.55% |
| Round Table Services, LLC | 339,391 | $998,000 | 0.31% |
| ARK Investment Management | 3,955,017 | $11,628,000 | 0.29% |
| Nikko Asset Management Americas, Inc. | 4,884,100 | $14,359,000 | 0.28% |
| WASATCH ADVISORS LP | 6,735,726 | $19,803,000 | 0.19% |
| Cedar Brook Financial Partners, LLC | 41,500 | $122,000 | 0.06% |
| Unified Trust Company, N.A. | 15,716 | $46,000 | 0.03% |
| Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors | 13,500 | $40,000 | 0.03% |
| STONERIDGE INVESTMENT PARTNERS LLC | 16,914 | $50,000 | 0.02% |
| Sumitomo Mitsui Trust Holdings, Inc. | 4,884,100 | $14,359,000 | 0.01% |